Atlas of Diagnostic Oncology
Mosby (Verlag)
978-0-7234-3206-7 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
The Atlas of Diagnostic Oncology comprises a superb collection of over 2000 clinical, radiologic, and histopathologic illustrations that cover all aspects of oncologic tumors and malignancies.
Organised into 18 chapters that reflect organ systems the Atlas consists of more than 2000 carefully selected images and explanatory captions coupled with text that provides essential information on pathology, diagnostic studies, staging and clinical manifestations. Both gross and microscopic pathology are generously illustrated, as are patterns of primary and metastatic disease and photographs of patients showing classic clinical features.
In this third edition each chapter is extensively revised with new images added and text updated, key changes incorporated are:New information on molecular biology
Changes to classification
Diagnosing abnormalities in oncogenes
In addition , a new chapter illustrating the side effects of chemotherapy is also included.
Expanded chapters include those on gastrointestinal tumors , sarcomas of bone and soft tissue, acute and chronic leukemias , Hodgkin's disease and Non-Hodgkins lymphomas, and multiple myeloma and plasma cell dyscrasias.Superb four colour photgraphs and line illustrations
Succinct text that draws attention to key diagnostic issues
A unique pictorial resource that complements treatment handbooks and major oncological texts
Over 400 new colour photographs
All new advances in molecular biology included
Revised cancer staging clasifications included
New chapter on diagnosing the side effects of chemotherapy
Arthur T. Skarin, MD, FACP, FCCP, earned his MD from the State University of New York at Buffalo in 1961, and received postgraduate training in internal medicine at the Millard Fillmore Teaching Hospital in Buffalo. After a fellowship in hematology and oncology at Boston City Hospital, he joined Brigham and Women's Hospital and Dana-Farber Cancer Institute (DFCI) in 1970. He served as Clinical Director of the DFCI Hematology Laboratory as well as Chairman of the Laboratory Committee from 1970 to 1998. He established the multimodality thoracic oncology clinic in 1975 and has served as Medical Director since then. During that time he also was chair of the human protection committee (IRB) for 12 years and became Associate Professor of Medicine at Harvard Medical School. He has been the Principal Investigator (PI) as well as site PI on numerous clinical research Phase I, II and III trials, both at DFCI Partners Cancer Care and the Cancer and Leukemia Group B (CALGB). He was appointed a Research Subject Advocate (RSA) in 2002 for NIH funded studies at the Brigham and Women's Hospital General Clinical Research Center (GCRC) and DFCI. Dr. Skarin is a board member of the American Journal of Oncology Review, the Journal of Cinical Oncology, Hospital Physician and also president of the Massachusetts Society of Clinical Oncologists. He has published 150 original articles, 97 abstracts, 67 chapters in books and 4 books.
The role of molecular probes and other markers in the diagnostic process
Radiographic evaluation of Cancer
Cancer of the head and neck
Lung Cancer and tumors of the heart and mediastinum
Cancer of the GI tract
Cancer of the Genitourinary Tract
Gynecologic Tumors and Malignancies
Breast Cancer
Endocrine Tumors and malignancies
Sarcomas of bone and soft tissue Skin Cancer
Neoplasms of the Central Nervous System
Acute and Chronic Leukemias
Hodgkin's Disease and non-Hodgkin's lymphomas
Multiple Myelomaand plasma cell dyscrasias
Solid Tumors in childhood
Aids associated malignancies
Side effects of chemotherapy
| Erscheint lt. Verlag | 15.10.2002 |
|---|---|
| Verlagsort | London |
| Sprache | englisch |
| Maße | 246 x 189 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| ISBN-10 | 0-7234-3206-6 / 0723432066 |
| ISBN-13 | 978-0-7234-3206-7 / 9780723432067 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
